Literature DB >> 8665349

Redistribution of myocardial perfusion during permanent dual chamber pacing in symptomatic non-obstructive hypertrophic cardiomyopathy: a quantitative positron emission tomography study.

J L Posma1, P K Blanksma, E E van der Wall.   

Abstract

Dual chamber pacing causes significant symptomatic improvement in many patients with hypertrophic cardiomyopathy. The mechanism behind this beneficial response is not fully understood. Positron emission tomography showed a redistribution of myocardial flow during pacing in a patient with non-obstructive hypertrophic cardiomyopathy. Early septal activation reduced septal fibre strain and blood flow and increased septal perfusion reserve.

Entities:  

Mesh：

Year:  1996        PMID： 8665349      PMCID： PMC484354          DOI： 10.1136/hrt.75.5.522

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  7 in total

1.  Effects of dual-chamber pacing in hypertrophic cardiomyopathy without obstruction.

Authors:  P H Seidelin; G A Jones; N A Boon
Journal:  Lancet       Date:  1992-08-08       Impact factor: 79.321

2.  Redistribution of myocardial fiber strain and blood flow by asynchronous activation.

Authors:  F W Prinzen; C H Augustijn; T Arts; M A Allessie; R S Reneman
Journal:  Am J Physiol       Date:  1990-08

3.  Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

Authors:  G Schuler; R Hambrecht; G Schlierf; J Niebauer; K Hauer; J Neumann; E Hoberg; A Drinkmann; F Bacher; M Grunze
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

4.  Relation between regional electrical activation time and subepicardial fiber strain in the canine left ventricle.

Authors:  T Delhaas; T Arts; F W Prinzen; R S Reneman
Journal:  Pflugers Arch       Date:  1993-04       Impact factor: 3.657

5.  Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

Authors:  L Fananapazir; N D Epstein; R V Curiel; J A Panza; D Tripodi; D McAreavey
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

6.  Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy.

Authors:  R O Cannon; D Tripodi; V Dilsizian; J A Panza; L Fananapazir
Journal:  Am J Cardiol       Date:  1994-03-15       Impact factor: 2.778

7.  Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET.

Authors:  P K Blanksma; A T Willemsen; J G Meeder; R M de Jong; R L Anthonio; J Pruim; W Vaalburg; K I Lie
Journal:  J Nucl Med       Date:  1995-01       Impact factor: 10.057
  7 in total
  3 in total

Review 1.  Application of animal and human PET in cardiac research.

Authors:  Quan Wang; Zhi-Gang He; Shun-Yuan Li; Mao-Hui Feng; Hong-Bing Xiang
Journal:  Am J Cardiovasc Dis       Date:  2018-06-15

Review 2.  Mechanisms and efficacy of LV pre-excitation for patients with heart failure and supra-normal systolic function.

Authors:  D A Kass
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

3.  Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy.

Authors:  J L Posma; P K Blanksma; E E Van Der Wall; W Vaalburg; H J Crijns; K I Lie
Journal:  Heart       Date:  1996-10       Impact factor: 5.994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.